Fluoride Treatment and Risk of Fracture In Osteoporosis Patients

Loading...
Thumbnail Image

Date

2018-03-14

Journal Title

Journal ISSN

Volume Title

Publisher

faculty of Basic Medical Science - Libyan International Medical University

Abstract

Description

Osteoporosis is common systemic skeletal disease characterized by low bone mass and microarchitectural deterioration of bone tissue, leading to enhanced bone fragility and a consequent increase in fracture risk” • More common in postmenopausal Sodium fluoride stimulates bone formation and increases cancellous-bone mass Sodium fluoride (NaF) was currently the only pharmacological agent capable of stimulating bone formation through a direct effect on the osteoblast

Keywords

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By

Creative Commons license

Except where otherwised noted, this item's license is described as Attribution 3.0 United States